Peers for comparison


Market capitalization
‪36.20 M‬ GBPNano cap
−0.02 GBP
‪−10.58 M‬ GBP
‪2.24 M‬ GBP
‪624.48 M‬
Beta (1Y)
−0.54
Next report date
Report period
EPS estimate
Revenue estimate

Company info


CEO
James Renwick McCullough
Headquarters
New York
Founded
2018
IPO date
Nov 6, 2018
ISIN
GB00BYWL4Y04
FIGI
BBG00LWH2C47
Identifiers
ISIN GB00BYWL4Y04
CFI code
ESVTFR
Renalytix Plc engages in the manufacturing of medical devices and equipment. It includes the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
EPS
Next:—
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


Markets don't sleep, here's what's going on with RENX at the moment:
– REG - Renalytix PLC - Notice of 2026 Annual General Meeting
– REG - Renalytix PLC - Holding(s) in Company
– RCS - Renalytix PLC - Conference attendance at Mello2026 Investor event

See more updates in real-time with our News Flow.
Renalytix Plc is scheduled to release its next earnings report on Apr 1, 2027.

Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release

How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
RENX stock is 3.38% volatile and has beta coefficient of −0.54.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like RENX are typically less volatile than smaller companies

Track every detail on Renalytix Plc stock chart and check out the list of the most volatile stocks — is Renalytix Plc there?
To understand the RENX stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — −0.93%
– 1 week — −4.46%
– 1 month — −1.83%

RENX all-time low was 1.60 GBX (Apr 27, 2026), and its highest price is 1,220.00 GBX (Jun 2, 2021). Find more dynamics in the Stock Heatmap and on the Renalytix Plc stock chart.
Renalytix Plc market capitalization is ‪35.87 M‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Renalytix Plc stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Renalytix Plc stacks up against other companies
The safest way to buy Renalytix Plc stocks is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade RENX directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
Investing in Renalytix Plc depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.

First, study Renalytix Plc financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency

Then explore our RENX technicals – signals based on essential indicators calculations:
– Today — sell
– 1-week — buy
– 1-month — sell

Combine fundamental and technical analysis for better results.
Renalytix Plc stock ticker depends on the exchange where it’s listed. On the LSE, its primary exchange, Renalytix Plc stocks trade under the symbol RENX.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.
Yes, you can track Renalytix Plc financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.
RENX net income for the last half-year is ‪−4.53 M‬ GBP, while the half-year before that showed ‪−6.05 M‬ GBP of net income which accounts for 25.03% change.

How to read this data:
– Track changes: Compare net income across periods to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one period: Consistency matters more than a single result

Follow other essential metrics in Renalytix Plc financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
No, Renalytix Plc does not currently pay dividends to its shareholders.

Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.

What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
RENX reached its all-time high of 1,220.00 GBX on Jun 2, 2021. Its all-time low was 1.60 GBX and was reached on Apr 27, 2026.

Explore the Renalytix Plc stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Renalytix Plc EBITDA is ‪−10.28 M‬ GBP, with an EBITDA margin of −460.00%.

EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.

What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures

What to look at next in Renalytix Plc statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
Analyst forecasts suggest a price range between 20.78 GBX and 20.78 GBX for RENX, based on current estimates.

Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions

Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance